Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era

被引:58
作者
Trotter, C
Borrow, R
Andrews, N
Miller, E
机构
[1] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England
[2] Withington Hosp, PHLS, Meningococcal Reference Unit, Manchester M20 2LR, Lancs, England
关键词
meningococcal infections; seroepidemiology; antibodies;
D O I
10.1016/S0264-410X(02)00630-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sera from an age-stratified sample of 1689 individuals, submitted to the PHLS Seroepidemiology Unit between 1996 and 1999 were tested for serum bactericidal antibodies to serogroup C meningococci. Titres decreased during infancy, presumably as maternal antibody waned, and increased in older teenagers, the peak age of meningococcal carriage. The prevalence of antibody titres greater than or equal to 8 was highest in adults, with an average of 25% of adults 25 years old or above with titres above this putative protective level. In the absence of vaccination, antibody may be generated from periods of carriage of serogroup C meningococci, from other meningococcal strains sharing non-capsular antigens, and other cross-reactive organisms. The inverse relationship between disease incidence and the prevalence of 'protective' antibody titres as described by Goldschneider et al. appears more consistent with a titre of greater than or equal to8 rather than greater than or equal to128, although the proportions 'protected' are much lower here than in Goldschneider's study. This study provides baseline antibody levels which will facilitate the evaluation of the meningococcal serogroup C conjugate vaccination programme. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1094 / 1098
页数:5
相关论文
共 17 条
[1]  
ANDREWS N, UNPUB VALIDATION SER
[2]   Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: Reevaluation of correlates of protection [J].
Borrow, R ;
Andrews, N ;
Goldblatt, D ;
Miller, E .
INFECTION AND IMMUNITY, 2001, 69 (03) :1568-1573
[3]   THE STONEHOUSE SURVEY - NASOPHARYNGEAL CARRIAGE OF MENINGOCOCCI AND NEISSERIA-LACTAMICA [J].
CARTWRIGHT, KAV ;
STUART, JM ;
JONES, DM ;
NOAH, ND .
EPIDEMIOLOGY AND INFECTION, 1987, 99 (03) :591-601
[4]   Conjugate meningococcal serogroup A and C vaccine: Reactogenicity and immunogenicity in United Kingdom infants [J].
Fairley, CK ;
Begg, N ;
Borrow, R ;
Fox, AJ ;
Jones, DM ;
Cartwright, K .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1360-1363
[5]   Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain [J].
Fernández, S ;
Arreaza, L ;
Santiago, I ;
Malvar, A ;
Berrón, S ;
Vazquez, JA ;
Hervada, X ;
Gestal, JJ .
EPIDEMIOLOGY AND INFECTION, 1999, 123 (03) :349-357
[6]   CROSS-ANTIGENICITY AND IMMUNOGENICITY BETWEEN CAPSULAR POLYSACCHARIDES OF GROUP-C NEISSERIA-MENINGITIDIS AND OF ESCHERICHIA-COLI K92 [J].
GLODE, MP ;
ROBBINS, JB ;
LIU, TY ;
GOTSCHLICH, EC ;
ORSKOV, I ;
ORSKOV, F .
JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (01) :94-102
[7]   CARRIAGE OF NEISSERIA-MENINGITIDIS AND NEISSERIA-LACTAMICA IN INFANTS AND CHILDREN [J].
GOLD, R ;
GOLDSCHNEIDER, I ;
LEPOW, ML ;
DRAPER, TF ;
RANDOLPH, M .
JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (02) :112-121
[8]   HUMAN IMMUNITY TO MENINGOCOCCUS .I. ROLE OF HUMORAL ANTIBODIES [J].
GOLDSCHNEIDER, I ;
GOTSCHLICH, EC ;
ARTENSTEIN, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (06) :1307-+
[9]   HUMAN IMMUNITY TO MENINGOCOCCUS .2. DEVELOPMENT OF NATURAL IMMUNITY [J].
GOLDSCHNEIDER, I ;
GOTSCHLICH, EC ;
ARTENSTEIN, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (06) :1327-+
[10]  
GRIFFISS JM, 1983, J IMMUNOL, V130, P2882